Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size.
Biomed Pharmacother. 2021 Jan;133:110825. doi: 10.1016/j.biopha.2020.110825. Epub 2020 Sep 30.
Biomed Pharmacother. 2021.
PMID: 33378989
Free PMC article.
Clinical Trial.